Imatinib ameliorates fibrosis in uraemic cardiac disease in BALB/c without improving cardiac function

Marcus Baumann, Kirsten Leineweber, Marion Tewiele, Kun Wu, Tobias R. Tuerk, Song Su, Mario Goessl, Thomas Buck, Benjamin Wilde, Uwe Heemann, Andreas Kribben, Oliver Witzke

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1817-1824
JournalNephrology Dialysis Transplantation
Volume25
Issue number6
DOIs
Publication statusPublished - Jun 2010

Keywords

  • BALB/c mice
  • Glivec/Gleevec
  • imatinib
  • remnant kidney model
  • 5/6 nephrectomy

Cite this

Baumann, M., Leineweber, K., Tewiele, M., Wu, K., Tuerk, T. R., Su, S., Goessl, M., Buck, T., Wilde, B., Heemann, U., Kribben, A., & Witzke, O. (2010). Imatinib ameliorates fibrosis in uraemic cardiac disease in BALB/c without improving cardiac function. Nephrology Dialysis Transplantation, 25(6), 1817-1824. https://doi.org/10.1093/ndt/gfp708